1-(6-Chloropyrimidin-4-yl)indoline

Catalog No. :
ACTHPG290
CAS No. :
293292-33-8
Molecular Formula :
C12H10ClN3
Molecular Weight :
231.69

IUPAC Name:1-(6-chloropyrimidin-4-yl)indoline

1-(6-Chloropyrimidin-4-yl)indoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$143.00Login to see priceInquiryInquiry
100mg98%$207.00Login to see priceInquiryInquiry
250mg98%$286.00Login to see priceInquiryInquiry
1g98%$676.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(6-Chloropyrimidin-4-yl)indoline
IUPAC Name1-(6-chloropyrimidin-4-yl)indoline
MDL No.MFCD13561829
Molecular FormulaC12H10ClN3
Molecular Weight231.69
SMILESClC1=CC(N2CCC3=C2C=CC=C3)=NC=N1
InChI KeyRSEMHHFXNIKRQH-UHFFFAOYSA-N
Synonym1-(6-CHLOROPYRIMIDIN-4-YL)INDOLINE;1-(6-Chloro-4-pyrimidinyl)indoline;1-(6-chloropyrimidin-4-yl)-2,3-dihydro-1H-indole;1H-Indole, 1-(6-chloro-4-pyrimidinyl)-2,3-dihydro-
CAS No.293292-33-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTHPG290 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFDCG958 route compound structure diagram
    ACFDCG9584765-77-9 In Stock
  2. Plus
  3. ACITKQ649 route compound structure diagram
    ACITKQ649496-15-1 In Stock
  4. Then
  5. ACTHPG290 route product structure diagram
    ACTHPG290293292-33-8
Inquiry

2. ACTHPG290 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTGQP732 route compound structure diagram
    ACTGQP732258506-74-0 In Stock
  2. Plus
  3. ACITKQ649 route compound structure diagram
    ACITKQ649496-15-1 In Stock
  4. Then
  5. ACTHPG290 route product structure diagram
    ACTHPG290293292-33-8
Inquiry

Comments (0)